Pittsburgh, PA — Pitt BioForge and Panther Life Sciences announced the successful completion of BioForge’s first manufacturing project, achieving what had long been considered one of the most ...

[Image from the Vaxess website] Vaxess Technologies today shared new preclinical data highlighting the capability of its drug delivery patch to deliver semaglutide. Semaglutide, a GLP-1 receptor ...

Army Training Network Interactive Training Doctrine, "How to conduct a training meeting." Training doctrine recognizes the need for training management to be routine and predictable. Army Doctrine ...

The HD-MAP vaccine patch. [Image courtesy of Vaxxas] Vaxxas announced that it began a multi-center Phase I clinical trial of a vaccine against avian flu using its high-density microarray patch. The ...

According to Precedence Research, the global microarray market size was estimated at USD 5.46 billion in 2023 and is projected to reach USD 13.81 billion by 2034, registering a CAGR of 8.8% from 2024 ...

The phase 1/2 randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...

A Phase I/II randomized trial compared results from the measles and rubella vaccine delivered by a microarray patch, a small sticking plaster-like device with an array of microscopic projections that ...

The market for microarray analysis has reached a mature phase and is on a strong growth path, driven by increasing demand for precision medicine and progress in genetic and genomic studies. It ...